Alemtuzumab: a guide to its use in relapsing–remitting multiple sclerosis Gillian M. KeatingKarly P. Garnock-Jones Adis Drug Clinical Q&A 09 September 2014 Pages: 337 - 341
Linaclotide: a guide to its use in irritable bowel syndrome with constipation in the EU Lily P. H. YangPaul L. McCormackKatherine A. Lyseng-Williamson Adis Drug Clinical Q&A 04 September 2014 Pages: 342 - 347
Corticosteroids are still the mainstay for treating relapses of Crohn’s disease, but should not be used for maintenance therapy Adis Medical Writers Disease Management 18 July 2014 Pages: 348 - 351
Consider systemic therapy for chronic, refractory or severe cutaneous small-vessel vasculitis Adis Medical Writers Disease Management 16 August 2014 Pages: 352 - 355
When necessary, use a proven and safe agent to treat hypertension in pregnancy Adis Medical Writers Drug Reactions & Interactions 18 July 2014 Pages: 356 - 360
First reports of serious adverse drug reactions in recent weeks Drug Reactions and Interactions 04 September 2014 Pages: 361 - 362
Pharmacokinetic drug interactions are unlikely when sodium–glucose cotransporters type 2 inhibitors are used to treat type 2 diabetes mellitus Adis Medical Writers Drug Reactions & Interactions 18 July 2014 Pages: 363 - 366